Skip to main content

News

Patient Reluctance to Take Bisphosphonates

The NY Times reports that millions of Americans with osteoporosis are driven to stop or not take bisphosphonate therapies over the fear of exceedingly rare side effects - osteonecrosis of the jaw (ONJ) and atypical femoral fractures (AFF).

Tendon Inflammation May Signal Early RA

Tenosynovitis may represent a preclinical phase of rheumatoid arthritis (RA).

Gastrointestinal Perforation Risk increased for Tofacitinib and Tocilizumab

Gastrointestinal perforations (GIP) are not historically believed to be a common or uncommon complication. Hence, when this was noted in the tocilizumab (TCZ) and tofacitinib (TOFA) developmental trials, it was a curious if not perplexing finding.

Patients Undertreated and Uninformed on Pain Meds and NSAIDs

Pain management in the U.S. is at a vexing crossroad. The news tells us that narcotics are increasingly being restricted for their dangerous side effects and inappropriate use.

Arhalofenate, URAT-1 Inhibitor, Being Developed for Gout

Good news for gout patients includes the recent approval of Zurampic (lesinurad), a URAT-1 inhibitor, and that effective urate-lowering therapy has significant long-term cardiovascular benefits. 

RheumNow Week in Review – 27 May 2016

Dr. Cush reviews highlights from this week on RheumNow.com.

Mosquito Arthritis

In the last two years there have been increasing reports of mosquito-borne infectious arthritides.  Dengue fever was best known until the introduction of viral infections due to chikungunya and Zika. 

IL-23 Inhibitor Effective in Crohn's Disease

Selective IL-23 inhibition has been touted to be the next great advance in the treatment of inflammatory bowel and psoriatic disease.

Tocilizumab Effective in PMR

Polymyalgia rheumatica (PMR) should be easy and responsive, but it can be a challenge and requires long-term steroid therapy. Problems often begin when steroid–induced side effects take their toll on a patient, especially in elderly adults.

Opioid Prescriptions in Decline

In an era of increasing fears over narcotic abuse and narcotic-related deaths, the number of opioid prescriptions in the United States is finally falling, the according to the NY Times. 

TB Management Questions

The following is a compilation of several frequently asked questions regarding tuberculosis (TB) testing or treatment in patients on a TNF inhibitor (TNFi) or other biologic agents.

ORBIT Study Shows Rituximab and TNF inhibitor Equivalence

The initial choice of biologic is crucial to long-term success. Yet there are few studies evaluating head-to-head differences in some of our most popular therapies.

RheumNow Week in Review - 19 May 2016

Dr. Jack Cush reviews this week's news and research highlights from RheumNow.com.

FDA Delays Ruling on Generic Labeling

The New York Times reports that the FDA has delayed its much anticipated ruling on generics until sometime in 2017. 

Musculoskeletal Complications of Hematologic Disorders Reviewed

Morais and colleagues have published an informative review of rheumatologic and musculoskeletal (MSK) disorders that may potentially befall those with benign or malignant blood disorders. It is important to be aware of these associations.

×